NX

Nuveen Select Tax-Free Income Portfolio

NXPFinancial ServicesNASDAQ

Asset Management

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$29.5M
+199.0% YoY
Net Income
$29.2M
+205.6% YoY

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Negative CrossoverHistogram -0.0044, negative momentum
Jul 2 MACD Positive CrossoverHistogram +0.0061, positive momentum
About Nuveen Select Tax-Free Income Portfolio

Part of the financial services sector, Nuveen Select Tax-Free Income Portfolio (NXP) is listed under Asset Management. The company carries a $910.6M market cap, placing it firmly in the small-cap category. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.

Key stats
Market Cap$910.6M
P/E (TTM)25.35
EPS$0.57
Beta0.34
52W Change+4.9%
Dividend Yield4.44%
ROE3.6%
Analysis

Nuveen Select Tax-Free Income Portfolio reports $5.9M in cash and $0 in total debt. Return on equity stands at 3.6%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $77K (2023) to $29.5M (2026), reflecting a 38171% increase over the period.

With a beta below 0.7, Nuveen Select Tax-Free Income Portfolio typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Nuveen Select Tax-Free Income Portfolio and its sector.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms